Position in MRK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$863,134
-$48,303 QoQ
Shares Held
6,717
-11.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#2,244
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $9,117,824 across 12 Drug Manufacturers - General names. MRK ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,426 | $2,909,817 | |
| 2 | JNJ |
Johnson & Johnson
|
9,783 | $2,484,588 | |
| 3 | ABBV |
AbbVie Inc.
|
8,090 | $2,035,767 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
6,717 | $863,134 | |
| 5 | AMGN |
Amgen Inc
|
1,126 | $407,747 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,222 | $280,727 | |
| 7 | PFE |
Pfizer Inc
|
2,704 | $65,112 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
648 | $37,337 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $863,134 | 6,717 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $911,437 | 7,577 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $812,817 | 7,722 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $751,593 | 8,955 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,414,272 | 17,866 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,892,320 | 21,082 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,878,281 | 18,881 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,202,836 | 19,398 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,412,738 | 19,489 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,580,546 | 19,557 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,214,305 | 20,311 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $2,100,488 | 20,403 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $2,506,386 | 21,721 | Shares | Sole | 2023-12-18 | |
| 2023-03-31 | $2,322,174 | 21,827 | Shares | Sole | 2023-12-18 | |
| 2022-12-31 | $2,386,090 | 21,506 | Shares | Sole | 2023-12-18 | |
| 2022-09-30 | $1,846,154 | 21,437 | Shares | Sole | 2023-12-19 | |
| 2022-06-30 | $1,953,134 | 21,423 | Shares | Sole | 2023-12-19 | |
| 2022-03-31 | $1,715,665 | 20,910 | Shares | Sole | 2023-12-19 | |
| 2021-12-31 | $1,491,107 | 19,456 | Shares | Sole | 2023-12-20 | |
| 2021-09-30 | $1,497,918 | 19,943 | Shares | Sole | 2023-12-20 | |
| 2021-06-30 | $1,508,660 | 19,399 | Shares | Sole | 2023-12-20 | |
| 2021-03-31 | $1,494,698 | 19,389 | Shares | Sole | 2023-12-20 | |
| 2020-12-31 | $1,490,640 | 18,223 | Shares | Sole | 2023-12-20 | |
| 2020-09-30 | $1,366,104 | 16,469 | Shares | Sole | 2023-12-20 | |
| 2020-06-30 | $1,033,747 | 13,368 | Shares | Sole | 2023-12-20 | |
| 2020-03-31 | $576,280 | 7,490 | Shares | Sole | 2023-12-21 | |
| No filing history on record for this holder in this stock. | ||||||